Scarica l'app Stockscreener
1.21
1.63%
-0.02
Dopo l'orario di chiusura:
1.21
Precedente Chiudi:
$1.23
Aprire:
$1.2
Volume 24 ore:
322.97K
Relative Volume:
0.75
Capitalizzazione di mercato:
$32.17M
Reddito:
$50,000
Utile/perdita netta:
$-45.93M
Rapporto P/E:
-0.6289
EPS:
-1.9241
Flusso di cassa netto:
$-23.62M
1 W Prestazione:
+0.83%
1M Prestazione:
-9.02%
6M Prestazione:
-43.46%
1 anno Prestazione:
-85.01%
Intervallo 1D:
$1.185
$1.225
Intervallo di 1 settimana:
$1.09
$1.255
Portata 52W:
$1.09
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Compare INMB vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.21 | 32.17M | 50,000 | -45.93M | -23.62M | -1.9241 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
INMune Bio, Inc. (NASDAQ:INMB) Q4 2025 earnings call transcript - MSN
Support Test: Whats the RSI of INmune Bio Inc stockWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn
INMB.O PE Ratio & Valuation, Is INMB.O Overvalued - Intellectia AI
INmune Bio (INMB) price target increased by 33.33% to 7.14 - MSN
INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript - Insider Monkey
INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely - finance.yahoo.com
S P Trends: Whats the profit margin of INmune Bio IncWeekly Trade Report & Weekly Stock Performance Updates - baoquankhu1.vn
INmune Bio, Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Earnings Call Summary | INmune Bio(INMB.US) Q4 2025 Earnings Conference - Moomoo
Inmune Bio Inc Stock: Recent 2025 Results Highlight Late-Stage Pipeline Progress Amid Cash Runway to - AD HOC NEWS
INmune Bio reports $45.9M loss, plans UK regulatory filing By Investing.com - Investing.com South Africa
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
INmune Bio Q4 2025 Earnings Call Transcript - MarketBeat
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategi - GuruFocus
INmune Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: INmune Bio highlights CORDStrom progress in Q4 2025 - Investing.com Canada
INmune Bio | 10-K: FY2025 Annual Report - Moomoo
INMB: CORDStrom nears regulatory filings as cash runway extends to Q1 2027 after $27.5M raised - TradingView
Pipeline reset at INmune Bio (NASDAQ: INMB) after CORDStrom gains and XPro setback - Stock Titan
INmune Bio reports $45.9M loss, plans UK regulatory filing - Investing.com UK
INmune Bio Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Short Squeeze: Will INmune Bio Inc outperform tech stocksTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn
INMune Bio FY 2025 earnings preview - MSN
INmune Bio Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
INmune Bio Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView
INMB Technical Analysis | Trend, Signals & Chart Patterns | INMUNE BIO INC (NASDAQ:INMB) - ChartMill
INmune Bio (INMB.US) will release its earnings report after the market close on March 30. - Moomoo
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th. - The Manila Times
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on ... - Bluefield Daily Telegraph
INmune Bio will discuss 2025 results and corporate update March 30 - stocktitan.net
Market Moves: Whats the RSI of INmune Bio Inc stock2026 Buyback Activity & Low Drawdown Investment Ideas - baoquankhu1.vn
If You Invested $1,000 in Inmune Bio Inc (INMB) - Stock Titan
Block Trades: How does INmune Bio Inc compare to its peersMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn
INMB PE Ratio & Valuation, Is INMB Overvalued - Intellectia AI
INMB Showcases Advancements in Alzheimer's Treatment at AD/PD 20 - GuruFocus
INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s - TipRanks
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease - The Manila Times
Alzheimer’s trial gets plenary spotlight as blood markers guide treatment - Stock Titan
INMB stock rises pre-market – what did the FDA say about its Alzheimer’s trial? - MSN
Rally Mode: Whats the profit margin of INmune Bio IncTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Outlook: Is INmune Bio Inc stock undervalued right nowPortfolio Risk Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Setup Watch: How liquid is INmune Bio Inc stockTrade Entry Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Will INmune Bio Inc benefit from geopolitical trends2026 Momentum & Free Community Supported Trade Ideas - baoquankhu1.vn
INmune Bio Inc Stock (ISIN: US45764T1060) Faces Analyst Hold Consensus Amid $8 Price Target - AD HOC NEWS
INmune Bio Receives $8 Consensus Price Target from Analysts - National Today
INmune Bio (NASDAQ:INMB) Stock Rating Upgraded by Lucid Cap Mkts - Defense World
Lucid Capital Markets upgrades INmune Bio (INMB) - MSN
INMB Stock Receives Major Upgrade from Lucid Capital Markets | I - GuruFocus
Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy - Investing.com Australia
Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy By Investing.com - Investing.com India
INmune Bio, Inc. (NASDAQ:INMB) Given Average Recommendation of “Reduce” by Analysts - Defense World
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):